Arcoma AB (OM: ARCOMA)
Health Care · Health Care Equipment & Supplies · SE
Skr8.10
0.00% today · -4.7% 1Y
Arcoma AB (OM: ARCOMA) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $12.24M and employs 31 people.
Over the last twelve months the share price has lost 4.7%, trading between 6.16 and 10.05.
Tweenvest scores Arcoma AB across four factors: quality 77/100, value 48/100, growth 0/100. Its strongest factor is quality.
ARCOMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.24M
- Revenue (TTM)
- $13.15M
- P/E
- 29.31
- EPS
- 0.28
- Dividend yield
- —
- Beta (5Y)
- 0.65
- 52-week high
- Skr10.05
- 52-week low
- Skr6.16
- Avg volume (3M)
- —
- Shares outstanding
- 14.31M
- Employees
- 31
- Next earnings
- —
About Arcoma AB
Arcoma AB is a global provider that designs, manufactures, and supplies cutting-edge radiology solutions. Their product line features advanced digital x-ray and radiography systems. These versatile systems are suitable for a wide array of radiographic applications and are utilized across various clinical environments, including general practice, musculoskeletal, thoracic, pediatric, and trauma/resuscitation units. The company distributes its products through a network of OEM partners. Arcoma AB was founded in 1990 and is headquartered in Växjö, Sweden.
- ISIN
- SE0006219176
- Founded
- 1990
- Listed since
- Nov 14, 2014
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $115.55 | -0.50% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.13 | -0.19% |
| Stryker CorporationNYSE: SYK | $126.81B | $333.03 | +0.74% |
| Medtronic plcNYSE: MDT | $116.66B | $91.59 | +0.49% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.65 | +0.94% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $47.77 | -4.19% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $91.77 | +0.99% |
Figures last refreshed Aug 18, 2026.